Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021

Incidence of invasive pneumococcal disease (IPD) has been low during the peak of the COVID-19 pandemic. In this study, we found that the IPD numbers again increased in Switzerland during the first six months of 2021 and that this coincides with the loosening of COVID-19 measures. Vaccine pneumococca...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Carlo, Küffer, Marianne, Leib, Stephen L., Hilty, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648035/
https://www.ncbi.nlm.nih.gov/pubmed/34723783
http://dx.doi.org/10.1080/22221751.2021.2000892
_version_ 1784610718191976448
author Casanova, Carlo
Küffer, Marianne
Leib, Stephen L.
Hilty, Markus
author_facet Casanova, Carlo
Küffer, Marianne
Leib, Stephen L.
Hilty, Markus
author_sort Casanova, Carlo
collection PubMed
description Incidence of invasive pneumococcal disease (IPD) has been low during the peak of the COVID-19 pandemic. In this study, we found that the IPD numbers again increased in Switzerland during the first six months of 2021 and that this coincides with the loosening of COVID-19 measures. Vaccine pneumococcal serotypes have continued to decrease and non-vaccine type serotype 23B has emerged (8% of the isolates in 2021). Worryingly, serotype 23B is associated with reduced susceptibility to penicillin.
format Online
Article
Text
id pubmed-8648035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-86480352021-12-07 Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021 Casanova, Carlo Küffer, Marianne Leib, Stephen L. Hilty, Markus Emerg Microbes Infect Letter Incidence of invasive pneumococcal disease (IPD) has been low during the peak of the COVID-19 pandemic. In this study, we found that the IPD numbers again increased in Switzerland during the first six months of 2021 and that this coincides with the loosening of COVID-19 measures. Vaccine pneumococcal serotypes have continued to decrease and non-vaccine type serotype 23B has emerged (8% of the isolates in 2021). Worryingly, serotype 23B is associated with reduced susceptibility to penicillin. Taylor & Francis 2021-12-04 /pmc/articles/PMC8648035/ /pubmed/34723783 http://dx.doi.org/10.1080/22221751.2021.2000892 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Casanova, Carlo
Küffer, Marianne
Leib, Stephen L.
Hilty, Markus
Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title_full Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title_fullStr Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title_full_unstemmed Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title_short Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021
title_sort re-emergence of invasive pneumococcal disease (ipd) and increase of serotype 23b after easing of covid-19 measures, switzerland, 2021
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648035/
https://www.ncbi.nlm.nih.gov/pubmed/34723783
http://dx.doi.org/10.1080/22221751.2021.2000892
work_keys_str_mv AT casanovacarlo reemergenceofinvasivepneumococcaldiseaseipdandincreaseofserotype23baftereasingofcovid19measuresswitzerland2021
AT kuffermarianne reemergenceofinvasivepneumococcaldiseaseipdandincreaseofserotype23baftereasingofcovid19measuresswitzerland2021
AT leibstephenl reemergenceofinvasivepneumococcaldiseaseipdandincreaseofserotype23baftereasingofcovid19measuresswitzerland2021
AT hiltymarkus reemergenceofinvasivepneumococcaldiseaseipdandincreaseofserotype23baftereasingofcovid19measuresswitzerland2021

Ejemplares similares